Catalyst Capital Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-42,828
Closed -$3.19M 569
2016
Q3
$3.38M Sell
42,828
-7,913
-16% -$675K 0.37% 61
2016
Q2
$4.61M Sell
50,741
-6,465
-11% -$547K 0.85% 30
2016
Q1
$4.86M Sell
57,206
-14,311
-20% -$1.06M 0.82% 48
2015
Q4
$5.65M Buy
71,517
+8,504
+13% +$670K 0.82% 44
2015
Q3
$4.44M Sell
63,013
-3,086
-5% -$254K 0.6% 70
2015
Q2
$5.96M Sell
66,099
-23,901
-27% -$2.3M 0.7% 60
2015
Q1
$9.05M Buy
+90,000
New +$9.08M 1.04% 24
2014
Q3
Sell
-45,711
Closed -$4.26M 515
2014
Q2
$4.26M Buy
+45,711
New +$4M 0.69% 53
2013
Q4
Sell
-8,910
Closed -$662K 341
2013
Q3
$662K Buy
+8,910
New +$668K 0.36% 118

Other funds holding MJN

Catalyst Capital Advisors's MJN Position: Q4 2016 in Review

Catalyst Capital Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q4 2016, closing a stake of 42,828 shares — an estimated $3.19M sold.

Catalyst Capital Advisors first reported a position in MJN in Q3 2013 and held it in 9 quarters. The position peaked at $9.05M in Q1 2015. 554 funds tracked by Wall St. Rank hold MJN as of Q4 2016.

  • Catalyst Capital Advisors reported no remaining Mead Johnson Nutrition Company position as of Q4 2016 after selling out during the quarter.
  • Catalyst Capital Advisors sold 42,828 Mead Johnson Nutrition Company shares in Q4 2016, an estimated $3.19M.
  • Catalyst Capital Advisors first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 9 quarters.
  • Catalyst Capital Advisors's Mead Johnson Nutrition Company position peaked at $9.05M in Q1 2015.
  • 554 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2016.

Based on Catalyst Capital Advisors's 13F filing for Q4 2016, filed 8 Feb 2017.